Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41 | 182 | 179 | 100 | 86 |
| Receivables | 53 | 48 | 14 | 244 | 66 |
| Inventories | 118 | 124 | 121 | 48 | 117 |
| Other current assets | 0 | 0 | 4 | 0 | 0 |
| TOTAL | $227 | $375 | $352 | $437 | $287 |
| Non-Current Assets | |||||
| PPE Net | 36 | 39 | 38 | 43 | 49 |
| Intangibles | 345 | 345 | 347 | 343 | 334 |
| Other Non-Current Assets | 0 | 0 | 0 | 47 | 0 |
| TOTAL | $382 | $384 | $385 | $433 | $382 |
| Total Assets | $609 | $758 | $737 | $871 | $669 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 16 | N/A |
| Accounts payable and accrued liabilities | 762 | 674 | 676 | 553 | 558 |
| TOTAL | $900 | $841 | $1,055 | $987 | $1,237 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $900 | $841 | $1,055 | $987 | $1,237 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,104 | 28,311 | 23,328 | 16,709 | 13,860 |
| Common Shares | 29 | 28 | 17 | 16 | 13 |
| Retained earnings | -12,774 | -12,407 | -11,338 | -10,817 | -10,125 |
| Other shareholders' equity | -63 | -74 | -75 | -86 | -109 |
| TOTAL | $-291 | $-82 | $-319 | $-117 | $-568 |
| Total Liabilities And Equity | $609 | $758 | $737 | $871 | $669 |